What should I do if I have blood exposure from an HIV positive individual?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Exposure from HIV-Positive Individual: Immediate Management Protocol

Immediately wash the exposed skin area thoroughly with soap and water, then seek emergency medical evaluation within 1 hour to initiate post-exposure prophylaxis (PEP), which must be started within 72 hours to be effective. 1, 2

Immediate First Aid (Within Minutes)

  • Wash the exposed area thoroughly with soap and water - this is the single most critical first step 3, 1, 2
  • Do NOT squeeze, scrub, or apply pressure to increase bleeding 1
  • If blood splashed into eyes, nose, or mouth, flush immediately with clean water or saline 3, 2
  • Document the time of exposure immediately, as timing is critical for PEP effectiveness 1, 4

Emergency Medical Evaluation (Within 1 Hour)

Time is critical: PEP effectiveness drops dramatically after 72 hours, with optimal results when started within the first hour. 1

Risk Assessment for Intact vs Non-Intact Skin

  • Intact skin exposure: The risk of HIV transmission through intact skin is virtually non-existent if washed within 15 minutes 5
  • Non-intact skin (cuts, abrasions, chapped skin, dermatitis): Higher risk and may warrant PEP consideration 2, 5
  • The actual transmission risk from blood exposure on non-intact skin is significantly lower than percutaneous needlestick injury (which is only 0.3-0.36%) 1, 6, 7

When to Initiate PEP

For non-intact skin exposure to blood from a known HIV-positive source, PEP should be considered and initiated immediately, even before complete risk assessment. 1, 2

  • Start PEP within 1 hour if possible, absolutely within 72 hours 1
  • Do not wait for source patient testing results to begin treatment 1, 8
  • PEP reduces HIV transmission risk by approximately 81% when started promptly 1, 7

Recommended PEP Regimen

The preferred regimen is bictegravir/emtricitabine/tenofovir alafenamide (single tablet once daily) for 28 days. 1

Alternative combinations include: 1

  • Dolutegravir plus tenofovir alafenamide/emtricitabine
  • Dolutegravir plus tenofovir disoproxil fumarate/lamivudine

Complete the full 28-day course - stopping early eliminates all protection. 1

Testing Protocol

Baseline Testing (Day 0)

  • HIV antibody or antigen/antibody combination test 1, 4
  • Hepatitis B surface antigen (HBsAg) and serology 1, 4
  • Hepatitis C antibody (anti-HCV) 1, 4
  • Complete blood count, renal and hepatic function (if starting PEP) 4
  • Pregnancy test if applicable 4

Source Patient Testing

  • HIV antibody (rapid testing preferred for quick decision-making) 3, 1, 4
  • Hepatitis B surface antigen 3, 4
  • Hepatitis C antibody 3, 4

Follow-Up Testing Schedule

  • HIV testing: at 6 weeks, 3 months, and 6 months post-exposure 3, 1, 4
  • Hepatitis C: anti-HCV and ALT at 4-6 months; consider HCV RNA at 4-6 weeks for earlier diagnosis 3, 4
  • Hepatitis B: If vaccine given, test anti-HBs 1-2 months after final dose 3, 4
  • PEP monitoring: Evaluate within 72 hours of starting, then monitor for drug toxicity every 2 weeks 3, 1, 4

Hepatitis B Management

If you are unvaccinated or incompletely vaccinated and the source is HBsAg-positive: 1, 2

  • Administer hepatitis B immune globulin (HBIG) within 24 hours (can give up to 7 days) 2
  • Begin hepatitis B vaccine series immediately 1, 2
  • Risk of HBV transmission without prophylaxis can exceed 30% 1, 4

Hepatitis C Considerations

  • No post-exposure prophylaxis exists for hepatitis C 3, 1, 2
  • Transmission risk is approximately 1.8% from percutaneous exposure 1, 4
  • Early identification through testing is the only approach 1, 2

Precautions During Follow-Up Period

For 6 months post-exposure: 1

  • Use barrier protection during all sexual activity 1
  • Do not donate blood, plasma, organs, tissue, or semen 1
  • Seek immediate medical evaluation for any acute illness (may indicate acute retroviral syndrome) 3, 1, 2

Common Pitfalls to Avoid

  • Delaying washing: The 15-minute window for washing is critical for reducing transmission risk 5
  • Waiting for source testing before starting PEP: Always start immediately if indicated, then reassess 2-4 days later 8
  • Incomplete PEP course: Stopping antiretrovirals early eliminates all protective benefit 1
  • Missing follow-up testing: HIV can take up to 6 months to become detectable 3, 1
  • Assuming intact skin is safe without washing: Even intact skin requires immediate thorough washing 2, 5

Documentation Requirements

Document immediately: 3, 4, 2

  • Date and time of exposure
  • Type of fluid (blood) and volume
  • Condition of skin (intact vs non-intact)
  • Source patient HIV status if known
  • All interventions and timing

References

Guideline

Immediate Post-Needlestick HIV Exposure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Immediate Management of Skin Exposure to Bloodborne Pathogens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Needlestick Injuries

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

HIV exposure through contact with body fluids.

Prescrire international, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.